Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finafloxacin in Acute Otitis Externa
NCT01535599Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in acute otitis externa (AOE) comparing AL-60371 with Vehicle (2 arms). Primary endpoint: Proportion of Patients With Clinical Cures at the Day 11 (TOC) Visit. Started Mar 2012; status: completed.
02
Drugs
finafloxacin
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT01535599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535599.